The Treg cells isolated from MS patients have generally been shown defective in their ability to suppress effector T cell responses and some of such Treg cells have also a decreased expression of crucial CTLA-4 as well as Foxp3 (30–36, 115, 116). The gene discussed is FOXP3; the disease is myeloid sarcoma.